COMPANY
Grove Biopharma
We create modular bionic building blocks with these peptide inputs, then assemble them into protein-scale molecules through a precision polymerization process. From company website Source · Oct 13, 2026
NIH awards 1
- NIH award 1R43NS130860-01A1 FY2023: $246,702 awarded for that fiscal year; activity R43 (SBIR); PI BERTIN, PAUL ANTHONY; recipient as written: GROVE BIOPHARMA, INC., CHICAGO, IL. Selective Activators of Nrf2 for Neur source ↗